MV-NIS treatment triggered cellular immunity against the patients' tumor. »
11/16/14

No association between IGF-I and EOC risk. »
05/28/14

Neoantigen landscape that is specifically present in tumors. »
11/20/14

AURKA/MDM2 combination therapy shows adequate bioavailability. »
11/16/14

siRNA-mediated knockdown of Ets-1 in human breast cancer cell lines also decreased colony growth. »
08/13/13

β1-mediated process outgrowth in BCa cells required the presence and activity of fyn kinase. »
11/06/13

miR-26a and MEG3 have important antitumor effects in TSCC pathogenesis. »
07/25/13

ET-1 overexpression may be due to DNA hypermethylation resulting in the silencing of miR-1 expression. »
07/24/14

In the presence of glucose, oxamate inhibited cell proliferation in a dose-dependent manner. »
07/13/14

Kazinol C markedly induced AMPK phosphorylation and significantly attenuated HT-29 colon cancer cell growth. »
05/15/14